Abstract
How to safely maintain open schools during a pandemic is still controversial. We aim to identify those measures that effectively control the spread of SARS-CoV-2 in Austrian schools. By control we mean that each source case infects less than one other person on average. We use Austrian data on 616 clusters involving 2,822 student-cases and 676 teacher-cases to calibrate an agent-based epidemiological model in terms of cluster size and transmission risk depending on age and clinical presentation. Considering a situation in which the B1.617.2 (delta) virus strain is dominant and parts of the population are vaccinated, we quantify the impact of non-pharmaceutical intervention measures (NPIs) such as room ventilation, reduction of class size, wearing of masks during lessons, vaccinations, and school entry testing by SARS-CoV2-antigen tests. In the tracing data we find that 40% of all clusters involved no more than two cases, and 3% of the clusters only had more than 20 cases. The younger the students, the more likely we found asymptomatic cases and teachers as the source case of the in-school transmissions. Based on this data, the model shows that different school types require different combinations of NPIs to achieve control of the infection spreading: If 80% of teachers and 50% of students are vaccinated, in primary schools, it is necessary to combine at least two of the above NPIs. In secondary schools, where contact networks of students and teachers become increasingly large and dense, a combination of at least three NPIs is needed. A sensitivity analysis indicated that poorly executed mitigation measures might increase the cluster size by a factor of more than 17 for primary schools and even higher increases are to be expected for the other school types. Our results suggest that school-type-specific combinations of NPIs together with vaccinations are necessary to allow for a controlled opening of schools under sustained community transmission of the SARS-CoV-2 delta variant. However, large clusters might still occur on an infrequent, however, regular basis.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
JS and ST acknowledge financial support from the Austrian Science Promotion Agency FFG under 882184 and JL and PK from the Vienna Science and Technology Fund WWTF under MA16-045. PK and ST are grateful for support from the Medizinisch-Wissenschaftlichen Fonds des Buergermeisters der Bundeshauptstadt Wien, no. CoVid004. The computational results presented have been achieved in part using the Vienna Scientific Cluster (VSC).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
No IRB and/or ethics committee approvals were necessary for this research.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The code for the agent based simulation model is openly available under an MIT license. Cluster data used to calibrate the model is available upon request.
